Covidien plc : Covidien Announces New Bipolar Resection Software Application for ForceTriad™ Energy Platform
07/12/2012| 07:05am US/Eastern
Recommend:
Latest software introduces new capability and expands use to
additional procedures
Covidien
(NYSE: COV), a leading global provider of healthcare products, today
announced the North American introduction of a new bipolar resection in
saline software application for its ForceTriad™ energy platform. With
this new application, surgeons may now perform transurethral resections
of the prostate using TissueFect™ sensing technology available with the
ForceTriad energy platform.
The new software application provides expanded capabilities without the
need for additional capital expenditures. Same-day deployment is
available to more than 10,000 installed ForceTriad energy platforms in
the U.S., using Covidien's Valleylab™ Exchange software update system.
"This product demonstrates our commitment to working with leading
companies in the endoscope industry to deliver economical healthcare
solutions," said Dan Voecks, Senior Director, Product Management,
Endomechanical and Intelligent Devices, Covidien. "With this software
application, Covidien continues its commitment to minimize cost for
hospitals, while providing healthcare facilities with advanced
technologies that further improve patient outcomes."
The ForceTriad is a multifunctional, software-based energy platform,
available worldwide, that uses TissueFect sensing technology to monitor
changes in tissue impedance 3,333 times per second and adjusts energy
output accordingly to deliver the appropriate amount of energy for the
desired tissue effect. With the new software application, the ForceTriad
energy platform has a wide range of initiation and power options, all on
one familiar user interface. These multi-use capabilities offer
additional value to healthcare facilities by providing the ability to
use the ForceTriad energy platform in a broader range of surgical
procedures and may negate the need to purchase additional hardware
equipment.
System upgrades are available for all new and existing ForceTriad
generators using Covidien's secure, internet-based Valleylab Exchange
software update system. The new capability is also compatible with
bipolar resectoscopes produced by Karl Storz Endoskope and Richard Wolf
Medical Instruments Corporation.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000
employees worldwide in more than 65 countries, and its products are sold
in over 140 countries. Please visit www.covidien.com
to learn more about our business.
John Jordan, 508-452-4891
Manager
Communications
john.jordan@covidien.com
or
Marguerite
Copel, 203-821-4720
Vice President
Communications
marguerite.copel@covidien.com
or
Coleman
Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Todd
Carpenter, 508-452-4363
Director
Investor Relations
todd.carpenter@covidien.com
© Business Wire 2012
Recommend :
